Insider · CIK 0001649119

Hata Yujiro S

Reports to the SEC for 3 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001649119

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+26.3K sh	$4.31	+$114K	717,033
2026-10-06	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−25.5K sh	$37.39	−$955K	691,495
2026-10-06	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−800 sh	$38.26	−$30.6K	690,695
2026-10-06	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−26.3K sh	—	—	23,116
2026-03-11	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2026-01-30	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+600K sh	—	—	600,000
2025-03-13	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2025-02-27	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+600K sh	—	—	600,000
2025-02-18	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.8K sh	$19.52	+$250K	690,695
2025-02-18	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12.8K sh	—	—	182,192
2024-05-16	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+34.4K sh	$4.31	+$148K	712,320
2024-05-16	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−30.1K sh	$41.73	−$1.26M	682,236
2024-05-16	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−4,349 sh	$42.37	−$184K	677,887
2024-05-16	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−34.4K sh	—	—	49,454
2024-05-15	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+83.9K sh	$4.31	+$361K	761,743
2024-05-15	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−53.6K sh	$42.57	−$2.28M	708,151
2024-05-15	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−29.8K sh	$43.48	−$1.29M	678,390
2024-05-15	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−503 sh	$44.12	−$22.2K	677,887
2024-05-15	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−83.9K sh	—	—	83,887
2024-05-14	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+56.7K sh	$4.31	+$244K	734,598
2024-05-14	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−54.4K sh	$41.60	−$2.26M	680,190
2024-05-14	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−2,303 sh	$41.84	−$96.3K	677,887
2024-05-14	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−56.7K sh	—	—	167,743
2024-03-06	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2024-03-01	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+480K sh	—	—	480,000
2024-02-09	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+23.6K sh	$4.31	+$102K	701,444
2024-02-09	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−23.6K sh	$45.54	−$1.07M	677,887
2024-02-09	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−23.6K sh	—	—	224,454
2024-02-08	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+75.8K sh	$4.31	+$327K	753,702
2024-02-08	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−75.8K sh	$45.15	−$3.42M	677,887
2024-02-08	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−75.8K sh	—	—	248,011
2024-02-01	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+628 sh	$4.31	+$2,706.68	678,515
2024-02-01	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−624 sh	$45.00	−$28.1K	677,891
2024-02-01	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−4 sh	$45.01	−$180.04	677,887
2024-02-01	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−628 sh	—	—	323,826
2024-01-16	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+62.7K sh	$4.31	+$270K	740,626
2024-01-16	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−62.7K sh	$40.17	−$2.52M	677,887
2024-01-16	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−62.7K sh	—	—	324,454
2024-01-12	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+12.3K sh	$4.31	+$52.8K	690,148
2024-01-12	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−12.3K sh	$40.04	−$491K	677,887
2024-01-12	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−12.3K sh	—	—	387,193
2023-12-15	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+75K sh	$4.31	+$323K	752,887
2023-12-15	IDYAIDEAYA Biosciences, Inc.S Sale	Director, President and CEO	SSale	−75K sh	$35.03	−$2.63M	677,887
2023-12-15	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−75K sh	—	—	399,454
2023-04-12	IDYAIDEAYA Biosciences, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.6K sh	$4.31	+$50K	677,887
2023-04-12	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.6K sh	—	—	474,454
2023-03-02	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,800
2023-02-24	IDYAIDEAYA Biosciences, Inc. · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	400,000
2022-06-23	XNCRXencor Inc · Stock Option (Right to Buy)A Award	Director	AAward	+21.4K sh	—	—	21,412
2022-03-03	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500

Recent filings

Accepted (ET)
Oct 84
Hata Yujiro S0001610717-26-000434
SEC(opens sec.gov)
Mar 134
Hata Yujiro S0002064832-26-000140
SEC(opens sec.gov)
Feb 24
Hata Yujiro S0001610717-26-000034
SEC(opens sec.gov)
Mar 144
Hata Yujiro S0001062993-25-005504
SEC(opens sec.gov)
Feb 284
Hata Yujiro S0001610717-25-000038
SEC(opens sec.gov)
Feb 194
Hata Yujiro S0001610717-25-000021
SEC(opens sec.gov)
May 164
Hata Yujiro S0001610717-24-000239
SEC(opens sec.gov)

Companies

Address

C/O IDEAYA BIOSCIENCES, INC. 5000 SHORELINE COURT, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080